Detalhe da pesquisa
1.
A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001.
Int J Clin Oncol
; 20(4): 650-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407559
2.
Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).
Cancer
; 120(21): 3329-3337, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041994
3.
Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas.
Cancer
; 118(3): 770-6, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21751200
4.
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.
Invest New Drugs
; 30(4): 1646-51, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21748296
5.
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336).
Invest New Drugs
; 27(5): 469-75, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18941712
6.
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
Lung Cancer
; 60(2): 259-63, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18006112
7.
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.
JAMA Oncol
; 3(7): 944-952, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28196207
8.
Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
J Clin Oncol
; 33(34): 4093-8, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527781
9.
Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.
Clin Cancer Res
; 21(7): 1583-90, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25589620
10.
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.
Cancer Chemother Pharmacol
; 68(6): 1595-602, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21556747
11.
Obesity is an independent prognostic variable in colon cancer survivors.
Clin Cancer Res
; 16(6): 1884-93, 2010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20215553
12.
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.
J Clin Oncol
; 28(10): 1772-9, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20194851
13.
Multiple Histology Phase II Trials.
Clin Cancer Res
; 15(13): 4256-62, 2009 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19549777
14.
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149).
J Neurooncol
; 86(3): 353-8, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18175205
15.
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial.
Cancer
; 113(3): 559-65, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18521920
16.
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
J Clin Oncol
; 26(33): 5360-7, 2008 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18955451
17.
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
J Clin Oncol
; 26(4): 626-32, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18235122
18.
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).
Am J Hematol
; 82(12): 1056-62, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17696203
19.
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.
J Clin Oncol
; 25(17): 2406-13, 2007 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-17557954
20.
Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group.
Invest New Drugs
; 20(1): 129-32, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12003189